213 related articles for article (PubMed ID: 10944516)
1. Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators.
Kodera Y; Takeyama K; Murayama A; Suzawa M; Masuhiro Y; Kato S
J Biol Chem; 2000 Oct; 275(43):33201-4. PubMed ID: 10944516
[TBL] [Abstract][Full Text] [Related]
2. Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer.
Zhou G; Cummings R; Li Y; Mitra S; Wilkinson HA; Elbrecht A; Hermes JD; Schaeffer JM; Smith RG; Moller DE
Mol Endocrinol; 1998 Oct; 12(10):1594-604. PubMed ID: 9773982
[TBL] [Abstract][Full Text] [Related]
3. Discrete roles for peroxisome proliferator-activated receptor gamma and retinoid X receptor in recruiting nuclear receptor coactivators.
Yang W; Rachez C; Freedman LP
Mol Cell Biol; 2000 Nov; 20(21):8008-17. PubMed ID: 11027271
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene.
Li M; Pascual G; Glass CK
Mol Cell Biol; 2000 Jul; 20(13):4699-707. PubMed ID: 10848596
[TBL] [Abstract][Full Text] [Related]
5. A regulatory role for RIP140 in nuclear receptor activation.
Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
[TBL] [Abstract][Full Text] [Related]
6. p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor alpha and beta by interacting directly with the N-terminal A/B domains.
Kobayashi Y; Kitamoto T; Masuhiro Y; Watanabe M; Kase T; Metzger D; Yanagisawa J; Kato S
J Biol Chem; 2000 May; 275(21):15645-51. PubMed ID: 10747867
[TBL] [Abstract][Full Text] [Related]
7. Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gamma.
Heinlein CA; Ting HJ; Yeh S; Chang C
J Biol Chem; 1999 Jun; 274(23):16147-52. PubMed ID: 10347167
[TBL] [Abstract][Full Text] [Related]
8. FK614, a novel peroxisome proliferator-activated receptor gamma modulator, induces differential transactivation through a unique ligand-specific interaction with transcriptional coactivators.
Fujimura T; Sakuma H; Konishi S; Oe T; Hosogai N; Kimura C; Aramori I; Mutoh S
J Pharmacol Sci; 2005 Dec; 99(4):342-52. PubMed ID: 16314690
[TBL] [Abstract][Full Text] [Related]
9. Overexpression and ribozyme-mediated targeting of transcriptional coactivators CREB-binding protein and p300 revealed their indispensable roles in adipocyte differentiation through the regulation of peroxisome proliferator-activated receptor gamma.
Takahashi N; Kawada T; Yamamoto T; Goto T; Taimatsu A; Aoki N; Kawasaki H; Taira K; Yokoyama KK; Kamei Y; Fushiki T
J Biol Chem; 2002 May; 277(19):16906-12. PubMed ID: 11884404
[TBL] [Abstract][Full Text] [Related]
10. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
11. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
Kubota T; Koshizuka K; Williamson EA; Asou H; Said JW; Holden S; Miyoshi I; Koeffler HP
Cancer Res; 1998 Aug; 58(15):3344-52. PubMed ID: 9699665
[TBL] [Abstract][Full Text] [Related]
12. Activation of PPARgamma coactivator-1 through transcription factor docking.
Puigserver P; Adelmant G; Wu Z; Fan M; Xu J; O'Malley B; Spiegelman BM
Science; 1999 Nov; 286(5443):1368-71. PubMed ID: 10558993
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.
Asano T; Wakisaka M; Yoshinari M; Iino K; Sonoki K; Iwase M; Fujishima M
Biochim Biophys Acta; 2000 Jun; 1497(1):148-54. PubMed ID: 10838168
[TBL] [Abstract][Full Text] [Related]
14. Both coactivator LXXLL motif-dependent and -independent interactions are required for peroxisome proliferator-activated receptor gamma (PPARgamma) function.
Chen S; Johnson BA; Li Y; Aster S; McKeever B; Mosley R; Moller DE; Zhou G
J Biol Chem; 2000 Feb; 275(6):3733-6. PubMed ID: 10660518
[TBL] [Abstract][Full Text] [Related]
15. 15-Deoxy-delta(12,14) prostaglandin J2: a putative endogenous promoter of adipogenesis suppresses the ob gene.
Sinha D; Addya S; Murer E; Boden G
Metabolism; 1999 Jun; 48(6):786-91. PubMed ID: 10381155
[TBL] [Abstract][Full Text] [Related]
16. Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
Tsujie M; Nakamori S; Okami J; Hayashi N; Hiraoka N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
Exp Cell Res; 2003 Sep; 289(1):143-51. PubMed ID: 12941612
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.
Yamamoto K; Ohki R; Lee RT; Ikeda U; Shimada K
Circulation; 2001 Oct; 104(14):1670-5. PubMed ID: 11581147
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma.
Park KS; Ciaraldi TP; Lindgren K; Abrams-Carter L; Mudaliar S; Nikoulina SE; Tufari SR; Veerkamp JH; Vidal-Puig A; Henry RR
J Clin Endocrinol Metab; 1998 Aug; 83(8):2830-5. PubMed ID: 9709955
[TBL] [Abstract][Full Text] [Related]
19. Suppression of rat thromboxane synthase gene transcription by peroxisome proliferator-activated receptor gamma in macrophages via an interaction with NRF2.
Ikeda Y; Sugawara A; Taniyama Y; Uruno A; Igarashi K; Arima S; Ito S; Takeuchi K
J Biol Chem; 2000 Oct; 275(42):33142-50. PubMed ID: 10930400
[TBL] [Abstract][Full Text] [Related]
20. PPARgamma ligand inhibits osteopontin gene expression through interference with binding of nuclear factors to A/T-rich sequence in THP-1 cells.
Oyama Y; Akuzawa N; Nagai R; Kurabayashi M
Circ Res; 2002 Feb; 90(3):348-55. PubMed ID: 11861425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
